By Scientia Professor Matthew Colm Kiernan

Journal articles

Henden L; Fearnley LG; Southwood D; Smith A; Rowe DB; Kiernan MC; Pamphlett R; Bahlo M; Blair IP; Williams KL, 2024, 'Short tandem repeat expansions in LRP12 are absent in cohorts of familial and sporadic amyotrophic lateral sclerosis patients of European ancestry', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25, pp. 644 - 647, http://dx.doi.org/10.1080/21678421.2024.2348636

Dharmadasa T; Pavey N; Tu S; Menon P; Huynh W; Mahoney CJ; Timmins HC; Higashihara M; Bos MVD; Shibuya K; Kuwabara S; Grosskreutz J; Kiernan MC; Vucic S, 2024, 'Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter', CLINICAL NEUROPHYSIOLOGY, 163, pp. 68 - 89, http://dx.doi.org/10.1016/j.clinph.2024.04.0101388-2457

Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC, 2023, 'Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis', Acta Neuropathologica Communications, 11, http://dx.doi.org/10.1186/s40478-023-01670-2

Kiernan MC; Halliday GM; Rowe DB; Tan RH, 2023, 'The importance of patient-centred drug development for amyotrophic lateral sclerosis', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12944

Pavey N; Hannaford A; Higashihara M; van den Bos M; Kiernan MC; Menon P; Vucic S, 2023, 'Utility of split hand index with different motor unit number estimation techniques in ALS', Clinical Neurophysiology, 156, pp. 175 - 182, http://dx.doi.org/10.1016/j.clinph.2023.09.018

Kiernan MC; Farrar MA, 2023, 'Emerging role for sphingolipids in the genetics of amyotrophic lateral sclerosis', Journal of Neurology Neurosurgery and Psychiatry, 95, pp. 101 - 102, http://dx.doi.org/10.1136/jnnp-2023-332719

Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA, 2023, 'Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia', Clinical Neurophysiology, 154, pp. 157 - 168, http://dx.doi.org/10.1016/j.clinph.2023.08.002

Silsby M; Yiannikas C; Fois AF; Ng K; Kiernan MC; Fung VSC; Vucic S, 2023, 'Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy', Journal of the Peripheral Nervous System, 28, pp. 415 - 424, http://dx.doi.org/10.1111/jns.12574

Farrar MA; Kiernan MC; Kariyawasam DS, 2023, 'Presymptomatic spinal muscular atrophy: a cautionary approach to the proposed new terminology', Brain, 146, pp. E65 - E66, http://dx.doi.org/10.1093/brain/awad061

Pinkerton M; Lourenco G; Pacheco MT; Halliday GM; Kiernan MC; Tan RH, 2023, 'Survival in sporadic ALS is associated with lower p62 burden in the spinal cord', Journal of Neuropathology and Experimental Neurology, 82, pp. 769 - 773, http://dx.doi.org/10.1093/jnen/nlad051

Timmins HC; Vucic S; Kiernan MC, 2023, 'Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis', Current Opinion in Neurology, 36, pp. 353 - 359, http://dx.doi.org/10.1097/WCO.0000000000001162

Kiernan MC; Park SB, 2023, 'Hyperexcitability, neurodegeneration, and disease progression in amyotrophic lateral sclerosis', Muscle and Nerve, 68, pp. 103 - 105, http://dx.doi.org/10.1002/mus.27843

Yang Y; Rowe D; McCann H; Shepherd CE; Kril JJ; Kiernan MC; Halliday GM; Tan RH, 2023, 'Treatment with the copper compound CuATSM has no significant effect on motor neuronal pathology in patients with ALS', Neuropathology and Applied Neurobiology, 49, http://dx.doi.org/10.1111/nan.12919

Willemse SW; Harley P; Van Eijk RPA; Demaegd KC; Zelina P; Pasterkamp RJ; Van Damme P; Ingre C; Van Rheenen W; Veldink JH; Kiernan MC; Al-Chalabi A; Van Den Berg LH; Fratta P; Van Es MA, 2023, 'UNC13A in amyotrophic lateral sclerosis: From genetic association to therapeutic target', Journal of Neurology Neurosurgery and Psychiatry, 94, pp. 649 - 656, http://dx.doi.org/10.1136/jnnp-2022-330504

Kiernan M, 2023, 'Case 14-2023: A Man with Redness of the Right Eye', NEW ENGLAND JOURNAL OF MEDICINE, 389, pp. 383 - 383, http://dx.doi.org/10.1056/NEJMc2307114

Kiernan MF; Gillmore JD; Gupta T, 2023, 'Slowly progressive descending facial nerve paralysis indicates hereditary gelsolin amyloidosis', LANCET, 401, pp. 2072 - 2072, http://dx.doi.org/10.1016/s0140-6736(23)01063-2

Vucic S; Stanley Chen KH; Kiernan MC; Hallett M; Benninger DH; Di Lazzaro V; Rossini PM; Benussi A; Berardelli A; Currà A; Krieg SM; Lefaucheur JP; Long Lo Y; Macdonell RA; Massimini M; Rosanova M; Picht T; Stinear CM; Paulus W; Ugawa Y; Ziemann U; Chen R, 2023, 'Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee', Clinical Neurophysiology, 150, pp. 131 - 175, http://dx.doi.org/10.1016/j.clinph.2023.03.010

Menon P; Pavey N; Aberra AS; van den Bos MAJ; Wang R; Kiernan MC; Peterchev AV; Vucic S, 2023, 'Dependence of cortical neuronal strength-duration properties on TMS pulse shape', Clinical Neurophysiology, 150, pp. 106 - 118, http://dx.doi.org/10.1016/j.clinph.2023.03.012

Vucic S; Menon P; Huynh W; Mahoney C; Ho KS; Hartford A; Rynders A; Evan J; Evan J; Ligozio S; Glanzman R; Hotchkin MT; Kiernan MC, 2023, 'Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension', Eclinicalmedicine, 60, http://dx.doi.org/10.1016/j.eclinm.2023.102036

Shimatani Y; Lin CSY; Matamala JM; Kiernan MC, 2023, 'Strength-duration properties and excitability of motor and sensory axons across different target thresholds', Journal of Neurophysiology, 129, pp. 1434 - 1446, http://dx.doi.org/10.1152/jn.00456.2022

Kiernan MC; Burke D; Tan RH, 2023, 'The lower motor neuron homunculus: function matters', Brain, 146, pp. E34 - E35, http://dx.doi.org/10.1093/brain/awad021

Henden L; Fearnley LG; Grima N; McCann EP; Dobson-Stone C; Fitzpatrick L; Friend K; Hobson L; Moi Fat SC; Rowe DB; D Silva S; Kwok JB; Halliday GM; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Pamphlett R; Adams L; Bahlo M; Blair IP; Williams KL, 2023, 'Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia', Science Advances, 9, http://dx.doi.org/10.1126/sciadv.ade2044

Pavey N; Menon P; van den Bos MAJ; Kiernan MC; Vucic S, 2023, 'Cortical inhibition and facilitation are mediated by distinct physiological processes', Neuroscience Letters, 803, http://dx.doi.org/10.1016/j.neulet.2023.137191

Krishnan D; Kiernan MC, 2023, 'Neurotoxic risks from over-the-counter vitamin supplements', Medical Journal of Australia, 218, pp. 304 - 306, http://dx.doi.org/10.5694/mja2.51851

Silsby M; Fois AF; Yiannikas C; Ng K; Kiernan MC; Fung VSC; Vucic S, 2023, 'Chronic inflammatory demyelinating polyradiculoneuropathy-associated tremor: Phenotype and pathogenesis', European Journal of Neurology, 30, pp. 1059 - 1068, http://dx.doi.org/10.1111/ene.15693

Mazumder S; Mccann H; D'silva S; Furlong S; Shepherd CE; Kril JJ; Halliday GM; Rowe DB; Kiernan MC; Tan RH, 2023, 'Riluzole is associated with decreasing neuritic plaque severity in amyotrophic lateral sclerosis', Brain, 146, pp. E17 - E19, http://dx.doi.org/10.1093/brain/awac467

Martinez-Valdes E; Enoka RM; Holobar A; McGill K; Farina D; Besomi M; Hug F; Falla D; Carson RG; Clancy EA; Disselhorst-Klug C; van Dieën JH; Tucker K; Gandevia S; Lowery M; Søgaard K; Besier T; Merletti R; Kiernan MC; Rothwell JC; Perreault E; Hodges PW, 2023, 'Consensus for experimental design in electromyography (CEDE) project: Single motor unit matrix', Journal of Electromyography and Kinesiology, 68, pp. 102726, http://dx.doi.org/10.1016/j.jelekin.2022.102726

Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2023, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, 17, pp. 222 - 236, http://dx.doi.org/10.1007/s11764-021-00988-x

Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB, 2023, 'Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes', Jnccn Journal of the National Comprehensive Cancer Network, 21, pp. 125 - 132, http://dx.doi.org/10.6004/jnccn.2022.7074

Kutlubaev MA; Caga J; Xu Y; Areprintseva DK; Pervushina EV; Kiernan MC, 2023, 'Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, pp. 14 - 23, http://dx.doi.org/10.1080/21678421.2022.2053721

Hannaford A; Byth K; Pavey N; Henderson RD; Mathers S; Needham M; Schultz D; Menon P; Kiernan MC; Vucic S, 2023, 'Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis', Muscle and Nerve, 67, pp. 17 - 24, http://dx.doi.org/10.1002/mus.27736

Moreno-Roco J; Del Valle L; Jiménez D; Acosta I; Castillo JL; Dharmadasa T; Kiernan MC; Matamala JM, 2023, 'Diagnostic utility of transcranial magnetic stimulation for neurodegenerative disease: a critical review', Dementia E Neuropsychologia, 17, http://dx.doi.org/10.1590/1980-5764-DN-2023-0048

Tse NY; Bocchetta M; Todd EG; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD; Ahmed RM, 2023, 'Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum', Neuroimage Clinical, 37, http://dx.doi.org/10.1016/j.nicl.2022.103281

Phan K; He Y; Bhatia S; Pickford R; Mcdonald G; Mazumder S; Timmins HC; Hodges JR; Piguet O; Dzamko N; Halliday GM; Kiernan MC; Kim WS, 2023, 'Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis', Brain Communications, 5, http://dx.doi.org/10.1093/braincomms/fcac340

Vucic S; Kiernan MC, 2023, 'Nanocrystalline gold (CNM-Au8): a novel bioenergetic treatment for ALS', Expert Opinion on Investigational Drugs, 32, pp. 783 - 785, http://dx.doi.org/10.1080/13543784.2023.2263368

Silsby M; Fois A; Ng K; Yiannikas C; Kiernan M; Fung V; Vucic S, 2023, 'N°51 – Phenotype and pathogenesis of upper limb tremor in CIDP', Clinical Neurophysiology, 150, pp. e88 - e88, http://dx.doi.org/10.1016/j.clinph.2023.03.060

Restuadi R; Steyn FJ; Kabashi E; Ngo ST; Cheng FF; Nabais MF; Thompson MJ; Qi T; Wu Y; Henders AK; Wallace L; Bye CR; Turner BJ; Ziser L; Mathers S; McCombe PA; Needham M; Schultz D; Kiernan MC; van Rheenen W; van den Berg LH; Veldink JH; Ophoff R; Gusev A; Zaitlen N; McRae AF; Henderson RD; Wray NR; Giacomotto J; Garton FC, 2022, 'Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1', Genome Medicine, 14, http://dx.doi.org/10.1186/s13073-021-01006-6

Willemse SW; Roes KCB; Van Damme P; Hardiman O; Ingre C; Povedano M; Wray NR; Gijzen M; de Pagter MS; Demaegd KC; Janse AFC; Vink RG; Sleutjes BTHM; Chiò A; Corcia P; Reviers E; Al-Chalabi A; Kiernan MC; van den Berg LH; van Es MA; van Eijk RPA, 2022, 'Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06906-5

Mazumder S; Kiernan MC; Halliday GM; Timmins HC; Mahoney CJ, 2022, 'The contribution of brain banks to knowledge discovery in amyotrophic lateral sclerosis: A systematic review', Neuropathology and Applied Neurobiology, 48, http://dx.doi.org/10.1111/nan.12845

Caga J; Kiernan MC; Piguet O, 2022, 'A Systematic Review of Caregiver Coping Strategies in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia', Journal of Geriatric Psychiatry and Neurology, 35, pp. 763 - 777, http://dx.doi.org/10.1177/08919887211060016

Li T; Park SB; Battaglini E; King MT; Kiernan MC; Goldstein D; Rutherford C, 2022, 'Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use', Quality of Life Research, 31, pp. 3091 - 3107, http://dx.doi.org/10.1007/s11136-022-03154-7

Park SB; Li T; Kiernan MC; Garg N; Wilson I; White R; Boggild M; McNabb A; Lee-Archer M; Taylor BV, 2022, 'Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia', Muscle and Nerve, 66, pp. 576 - 582, http://dx.doi.org/10.1002/mus.27698

Noto YI; Kiernan MC, 2022, 'Hyperexcitability and ALS', Journal of Neurology Neurosurgery and Psychiatry, 93, pp. 1027, http://dx.doi.org/10.1136/jnnp-2021-328756

Kiernan MC, 2022, 'Brainspotting: Adventures in Neurology', Journal of Neurology Neurosurgery and Psychiatry, 93, pp. 800 - 801, http://dx.doi.org/10.1136/jnnp-2022-329455

De Oliveira HM; Silsby M; Jaiser SR; Lai HM; Pavey N; Kiernan MC; Williams TL; Vucic S; Baker MR, 2022, 'Electrodiagnostic findings in facial onset sensory motor neuronopathy (FOSMN)', Clinical Neurophysiology, 140, pp. 228 - 238, http://dx.doi.org/10.1016/j.clinph.2022.04.020

Grima N; Henden L; Fearnley LG; Rowe DB; D'Silva S; Pamphlett R; Adams L; Kiernan MC; Mazumder S; Timmins HC; Zoing M; Bahlo M; Blair IP; Williams KL, 2022, 'NEK1 and STMN2 short tandem repeat lengths are not associated with Australian amyotrophic lateral sclerosis risk', Neurobiology of Aging, 116, pp. 92 - 95, http://dx.doi.org/10.1016/j.neurobiolaging.2022.04.012

Tse NY; Tu S; Chen Y; Caga J; Dobson-Stone C; Kwok JB; Halliday GM; Ahmed RM; Hodges JR; Piguet O; Kiernan MC; Devenney EM, 2022, 'Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights', Journal of Neurology, 269, pp. 4241 - 4252, http://dx.doi.org/10.1007/s00415-022-11049-3

Kiernan M, 2022, 'Response to "A rare case of mucoepidermoid carcinoma ex pleomorphic adenoma of the lacrimal gland"', ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 41, pp. 522 - 523, http://dx.doi.org/10.1080/01676830.2022.2042326

Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, 30, pp. 5965 - 5974, http://dx.doi.org/10.1007/s00520-022-07024-3

Cornblath DR; Kiernan MC; Kimura J; Koltzenburg M; Lewis RA; Parry GJ; Pollard JD; Sumner AJ, 2022, 'Letter to the Editor re "Complete Foot Drop With Normal Electrodiagnostic Studies: Sunderland 'Zero' Ischemic Conduction Block of the Common Peroneal Nerve" by Peters and Colleagues.', Annals of Plastic Surgery, Publish Ahead of Print, http://dx.doi.org/10.1097/sap.0000000000003245

Back to profile page